DUPONT CAPITAL MANAGEMENT CORP - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 139 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2015$525,000
-7.7%
14,3250.0%0.01%0.0%
Q4 2014$569,000
+5.6%
14,325
-46.9%
0.01%
+11.1%
Q3 2014$539,000
+100.4%
26,995
+35.6%
0.01%
+125.0%
Q2 2014$269,000
+24.0%
19,9150.0%0.00%0.0%
Q1 2014$217,000
-19.3%
19,9150.0%0.00%
-20.0%
Q4 2013$269,00019,9150.01%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2015
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders